An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety and tolerability of brexanolone
in participants with tinnitus following a single 6-hour continuous intravenous (IV) infusion.